A closed biological production process reduces risks in drug manufacturing by diminishing the risk of contamination. This is true for mAbs, vaccines, bioconjugates, cell therapies, and gene therapies. Incorporating these technologies early in production makes scaling up easier.
With industry-leading turnaround times, we deliver high performing, inert, and low E&L solutions for single-use and full-scale processes in upstream, downstream, fill/finish, and oligonucleotide applications. Our comprehensive set of bag solutions, motion bioreactor bags, mixing systems, and microcarrier separation systems meets emerging requirements of fast-growing, bioprocessing applications. We can customize process solutions and deliver with speed to meet tight development timelines. We also provide a complete line of accessories, tubing, fittings, and related products to fill any company's bioprocessing needs.
Our single-use solutions support both fed batch and continuous bioprocessing for mAbs, vaccines, bioconjugates, cell therapies, and gene therapies. We can customize them to fit into any bioprocess including cell growth, separation, mixing, and storage. We combine product innovation and quick-turn response to deliver critical solutions for your upstream and downstream operations.
Our single-use solutions are customizable to fit into any bioprocess including separation, mixing, and storage. We combine product innovation and quick-turn response to deliver critical solutions for your downstream operations. Our comprehensive set of bag solutions, mixing systems, and particle counting technologies meet the emerging requirements of single-use bioprocessing applications.
Engineered oligonucleotide sequences are constructed and functionalized using our linking agents including phosphitylating or phosphorylating compounds. These formulated drug compounds built with oligonucleotides can be used in therapeutics where they are introduced into the body and can inhibit gene expression or provoke a biological response at the cellular level.